Cynata Therapeutics (ASX:CYP) has had its induced pluripotent stem cell (iPSC) derived mesenchymal stem cell (MSCs) verified ...

Investigation of the molecular mechanisms underpinning complex liver diseases and their pathology is an emerging goal of stem cell scope. Human induced pluripotent stem cells (hiPSCs) derived from ...

Stem cell engineering and CRISPR were used to create mice with two male parents. Could we use this technique on humans?

Progress in three-dimensional cell culture and microfluidic devices has enabled the generation of human cardiac models that faithfully recapitulate key aspects of human physiology. In this review, we ...

A woman with heart failure was kept alive long enough to receive a heart transplant, in part thanks to newly developed ...

World-renowned stem cell scientists will gather in Kyoto, Japan for the International Society for Stem Cell Research (ISSCR) ...

A new biological patch, designed from heart cells grown in the laboratory, could bring a glimmer of hope in the treatment of ...

About Fate Therapeutics, Inc. Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a ...

First Mouse With Two Male Parents to Reach Adulthood Jan. 28, 2025 — A team of stem cell scientists have successfully used embryonic stem cell engineering to create a bi-paternal mouse -- a ...

Pluristyx, a leading provider of innovative, unmodified, and gene-edited induced pluripotent stem cell (iPSC) lines, submitted a Type II Drug Master File (DMF) to the U.S. Food and Drug Administration ...

The Global Stem Cell Therapy For Diabetes Related Conditions market industry is primarily driven by the continuous advancements in technology.